|
US4782071A
(en)
|
1986-11-03 |
1988-11-01 |
Warner-Lambert Company |
Tetrasubstituted urea cholinergic agents
|
|
SK282252B6
(sk)
|
1995-01-11 |
2001-12-03 |
Samjin Pharmaceutical Co., Ltd. |
Piperazínové deriváty a farmaceutický prostriedok s ich obsahom
|
|
TW360653B
(en)
|
1995-03-01 |
1999-06-11 |
Janssen Pharmaceutica Nv |
A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
|
|
EP1100511A2
(en)
|
1998-06-08 |
2001-05-23 |
Sambasiva R. Chavali |
Inhibition of delta-9-desaturase activity by saponins
|
|
US6107313A
(en)
|
1998-10-02 |
2000-08-22 |
Combichem, Inc. |
Dopamine receptor antagonists
|
|
US20070087363A1
(en)
|
1998-12-22 |
2007-04-19 |
Myriad Genetics, Incorporated |
Therapeutic methods, compounds and compositions
|
|
EP1193255A4
(en)
*
|
1999-07-01 |
2002-08-07 |
Ajinomoto Kk |
HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS IN MEDICINE
|
|
CA2374995C
(en)
|
1999-07-20 |
2010-12-07 |
Dow Agrosciences Llc |
Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
|
|
CA2376275A1
(en)
|
1999-08-20 |
2001-03-01 |
Michael John Ricks |
Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
|
|
EP1315831B8
(en)
|
2000-02-24 |
2010-09-01 |
Xenon Pharmaceuticals Inc. |
Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
|
|
WO2001096308A1
(en)
|
2000-06-12 |
2001-12-20 |
Eisai Co., Ltd. |
1,2-dihydropyridine compounds, process for preparation of the same and use thereof
|
|
AU2001264376A1
(en)
|
2000-06-15 |
2001-12-24 |
Chaconne Nsi Co., Ltd. |
Urea derivative useful as an anti-cancer agent and process for preparing same
|
|
WO2002040666A2
(en)
|
2000-11-17 |
2002-05-23 |
Xenon Genetics Inc. |
Fat regulated genes, uses thereof, and compounds for modulating same
|
|
US6995162B2
(en)
*
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US20050256068A1
(en)
|
2001-05-18 |
2005-11-17 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
|
|
US20050043256A1
(en)
|
2001-07-30 |
2005-02-24 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of stearoyl-CoA desaturase expression
|
|
US6727247B2
(en)
|
2001-12-10 |
2004-04-27 |
Hoffman-La Roche Inc. |
Substituted benzothiazole amide derivatives
|
|
EP1499628A4
(en)
|
2002-02-20 |
2005-06-15 |
Sirna Therapeutics Inc |
RNA-Interferent-mediated inhibition of expression of the steroaryl-COA-desaturase (SCD) gene using SINA (Short Interfering Nucleic Acid)
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
AU2003264018A1
(en)
|
2002-08-09 |
2004-02-25 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
MXPA05001603A
(es)
|
2002-08-13 |
2005-04-25 |
Warner Lambert Co |
Derivados monociclicos como inhibidores de metaloproteinasa de matriz.
|
|
JP2006516250A
(ja)
|
2002-12-18 |
2006-06-29 |
サイトビア インコーポレイティッド |
カスパーゼ活性化剤およびアポトーシス誘導物質としての３，５−二置換−［１，２，４］−オキサジアゾールおよびそれらの誘導体ならびにそれらの使用
|
|
EP1635800A2
(en)
*
|
2003-06-10 |
2006-03-22 |
Kalypsys, Inc. |
Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
|
|
WO2005011654A2
(en)
|
2003-07-29 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
|
KR20060037410A
(ko)
|
2003-07-30 |
2006-05-03 |
제논 파마슈티칼스 인크. |
피리다진 유도체 및 그의 치료제로서의 용도
|
|
EP2316827B1
(en)
|
2003-07-30 |
2016-01-27 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
|
US7754711B2
(en)
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
ES2397389T3
(es)
|
2003-07-30 |
2013-03-06 |
Xenon Pharmaceuticals Inc. |
Derivados de piridilo y su uso como agentes terapéuticos
|
|
KR20060037409A
(ko)
|
2003-07-30 |
2006-05-03 |
제논 파마슈티칼스 인크. |
피페라진 유도체 및 그의 치료제로서의 용도
|
|
US7759348B2
(en)
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
MXPA06001480A
(es)
*
|
2003-08-06 |
2006-05-15 |
Pfizer Prod Inc |
Compuestos de oxazol para el tratamiento de trastornos neurodegenerativos.
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
US20060216292A1
(en)
|
2003-09-05 |
2006-09-28 |
Cellzome Ag |
Treatment of neurodegenerative diseases
|
|
US7973169B2
(en)
*
|
2003-09-06 |
2011-07-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
CA2544502A1
(en)
|
2003-11-25 |
2005-06-09 |
Wisconsin Alumni Research Foundation |
Vitamin d analogs for obesity prevention and treatment
|
|
US8207147B2
(en)
|
2003-12-24 |
2012-06-26 |
Prosidion Limited |
Heterocyclic derivatives as GPCR receptor agonists
|
|
JP2005213233A
(ja)
|
2004-02-02 |
2005-08-11 |
Fuji Oil Co Ltd |
肝臓ステアロイル‐ＣｏＡ不飽和化酵素１合成抑制剤
|
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
|
EP1758991B1
(en)
|
2004-06-25 |
2013-01-16 |
E.I. Du Pont De Nemours And Company |
Delta-8 desaturase and its use in making polyunsaturated fatty acids
|
|
BRPI0418939A
(pt)
|
2004-07-06 |
2008-04-08 |
Xenon Pharmaceuticals Inc |
derivados de nicotinamida e sua utilização como agentes terapêuticos
|
|
ES2325836T3
(es)
|
2004-07-26 |
2009-09-21 |
Merck Serono Sa |
Derivados de la n.hidroxiamida y uso de los mismos.
|
|
DK1778837T3
(da)
|
2004-08-09 |
2008-08-04 |
Cellzome Ag |
Behandling af neurodegenerative sygdomme ved anvendelse af SCD4-inhibitorer
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
CA2580856A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
US7951805B2
(en)
|
2004-09-20 |
2011-05-31 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
EP2316458A1
(en)
|
2004-09-20 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
US7767677B2
(en)
|
2004-09-20 |
2010-08-03 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
JP4958787B2
(ja)
|
2004-09-20 |
2012-06-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリジン誘導体
|
|
EP1799667B1
(en)
|
2004-09-20 |
2013-03-20 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
CN101083986A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
双环杂环衍生物及其作为硬脂酰CoA去饱和酶(SCD)抑制剂的用途
|
|
EP2289510A1
(en)
|
2004-09-20 |
2011-03-02 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
SG161261A1
(en)
|
2004-11-10 |
2010-05-27 |
Incyte Corp |
Lactam compounds and their use as pharmaceuticals
|
|
CA2588412A1
(en)
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
|
|
US20060167044A1
(en)
|
2004-12-20 |
2006-07-27 |
Arnaiz Damian O |
Piperidine derivatives and their use as anti-inflammatory agents
|
|
KR20070091038A
(ko)
|
2004-12-24 |
2007-09-06 |
프로시디온 리미티드 |
Ｇ-단백질 결합 수용체(ｇｐｒ116) 효능제 및 비만 및당뇨병을 치료하기 위한 이의 용도
|
|
BRPI0517423A
(pt)
|
2004-12-27 |
2008-10-07 |
Astrazeneca Ab |
composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
|
|
WO2006074025A1
(en)
|
2004-12-30 |
2006-07-13 |
Janssen Pharmaceutica N.V. |
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
|
|
ATE472327T1
(de)
|
2005-01-07 |
2010-07-15 |
Hoffmann La Roche |
Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
|
|
GT200600046A
(es)
|
2005-02-09 |
2006-09-25 |
|
Terapia de combinacion
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
WO2006125194A2
(en)
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their uses as therapeutic agents
|
|
WO2006125181A2
(en)
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Piperidine derivatives and their use as stearoyl-coa desaturase modulators
|
|
WO2007044085A2
(en)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Heteroaryl compounds and their uses as therapeutic agents
|
|
WO2006125179A1
(en)
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Tricyclic compounds and their uses as therapeutic agents
|
|
WO2007046868A2
(en)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Thiazolidine derivatives and their uses as therapeutic agents
|
|
EP2029138A1
(en)
|
2005-06-03 |
2009-03-04 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
EP1902051A1
(en)
|
2005-06-09 |
2008-03-26 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2007009236A1
(en)
|
2005-07-20 |
2007-01-25 |
Merck Frosst Canada Ltd. |
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
AU2006315025A1
(en)
|
2005-11-15 |
2007-05-24 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2007076055A2
(en)
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
MX2008008529A
(es)
|
2005-12-29 |
2008-09-26 |
Organon Nv |
Inhibidores de amida hidrolasa de acido graso.
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
WO2007136746A2
(en)
|
2006-05-19 |
2007-11-29 |
Xenon Pharmaceuticals Inc. |
Macrocyclic compounds and their uses as stearoyl-coa desaturase
|
|
EP2027121A1
(en)
|
2006-05-22 |
2009-02-25 |
Merck Frosst Canada Ltd. |
Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
DE602007010287D1
(de)
|
2006-06-05 |
2010-12-16 |
Novartis Ag |
Organische verbindungen
|
|
WO2007143823A1
(en)
|
2006-06-12 |
2007-12-21 |
Merck Frosst Canada Ltd. |
Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US7754745B2
(en)
|
2006-06-13 |
2010-07-13 |
Merck Frosst Canada Ltd. |
Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2008003753A1
(en)
|
2006-07-07 |
2008-01-10 |
Biovitrum Ab (Publ) |
Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
|
|
US8080659B2
(en)
|
2006-07-11 |
2011-12-20 |
Emory University |
CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
|
|
WO2008008852A2
(en)
|
2006-07-11 |
2008-01-17 |
Emory University |
Cxcr4 antagonists including heteroatoms for the treatment of medical disorders
|
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
|
AU2007283401A1
(en)
|
2006-08-09 |
2008-02-14 |
Merck Frosst Canada Ltd. |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
|
PE20110371A1
(es)
|
2006-08-15 |
2011-06-24 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA
|
|
WO2008024139A2
(en)
|
2006-08-18 |
2008-02-28 |
N.V. Organon |
Inhibitors of fatty acid amide hydrolase
|
|
JPWO2008023720A1
(ja)
|
2006-08-23 |
2010-01-14 |
アステラス製薬株式会社 |
ウレア化合物又はその塩
|
|
BRPI0719122A2
(pt)
|
2006-08-24 |
2013-12-10 |
Novartis Ag |
Compostos orgânicos
|
|
WO2008029266A1
(en)
|
2006-09-08 |
2008-03-13 |
Glenmark Pharmaceuticals S.A. |
Stearoyl coa desaturase inhibitors
|
|
MX2009003080A
(es)
|
2006-09-22 |
2009-04-02 |
Novartis Ag |
Compuestos organicos heterociclicos.
|
|
US7893066B2
(en)
|
2006-10-05 |
2011-02-22 |
Gilead Palo Alto, Inc. |
Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors
|
|
RU2009112397A
(ru)
|
2006-10-05 |
2010-10-10 |
Си Ви ТЕРАПЬЮТИКС, ИНК (US) |
Бициклические азотсодержащие гетероциклические соединения для применения в качестве ингибиторов стеароил соа десатуразы
|
|
US20090325956A1
(en)
*
|
2006-10-13 |
2009-12-31 |
Takahiko Taniguchi |
Aromatic amine derivative and use thereof
|
|
US20100004245A1
(en)
|
2006-10-20 |
2010-01-07 |
Merck Frosst Canada Ltd. |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2008057280A1
(en)
|
2006-10-27 |
2008-05-15 |
Amgen Inc. |
Multi-cyclic compounds and methods of use
|
|
WO2008056687A1
(en)
|
2006-11-09 |
2008-05-15 |
Daiichi Sankyo Company, Limited |
Novel spiropiperidine derivative
|
|
JP2010510201A
(ja)
|
2006-11-20 |
2010-04-02 |
グレンマーク・ファーマシューティカルズ・エスエー |
ステアリン酸ＣｏＡ脱飽和酵素阻害剤としてのアセチレン誘導体
|
|
SG173409A1
(en)
|
2006-11-24 |
2011-08-29 |
Ac Immune Sa |
N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers
|
|
TW200826936A
(en)
|
2006-12-01 |
2008-07-01 |
Merck Frosst Canada Ltd |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
CN101589039B
(zh)
|
2006-12-01 |
2012-09-05 |
默克弗罗斯特加拿大有限公司 |
作为硬脂酰辅酶a △-9去饱和酶抑制剂的氮杂环烷衍生物
|
|
RU2009127095A
(ru)
|
2006-12-15 |
2011-01-20 |
Эбботт Лэборетриз (Us) |
Новые оксадиазольные соединения
|
|
AU2007336238A1
(en)
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as SCD inhibitors
|
|
GB0625605D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
GB0625654D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
GB0625594D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
GB0625604D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
US20100210649A1
(en)
|
2006-12-21 |
2010-08-19 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinones and furan-containing compounds
|
|
AR064965A1
(es)
|
2007-01-26 |
2009-05-06 |
Merck Frosst Canada Inc |
Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa
|
|
WO2008096746A1
(ja)
|
2007-02-06 |
2008-08-14 |
Takeda Pharmaceutical Company Limited |
スピロ化合物およびその用途
|
|
EP2125799A1
(en)
|
2007-02-28 |
2009-12-02 |
Smithkline Beecham Corporation |
Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
|
|
US20080255153A1
(en)
|
2007-03-28 |
2008-10-16 |
Biovitrum Ab (Publ) |
New compounds
|
|
WO2008120744A1
(ja)
|
2007-03-30 |
2008-10-09 |
Japan Tobacco Inc. |
５員環アミド化合物およびその用途
|
|
WO2008120759A1
(ja)
|
2007-03-30 |
2008-10-09 |
Japan Tobacco Inc. |
ウレア化合物およびその用途
|
|
WO2008123469A1
(ja)
|
2007-03-30 |
2008-10-16 |
Japan Tobacco Inc. |
６員環アミド化合物およびその用途
|
|
US7662819B2
(en)
|
2007-04-09 |
2010-02-16 |
Gilead Palo Alto, Inc. |
Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors
|
|
US20080255161A1
(en)
|
2007-04-11 |
2008-10-16 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
AU2008241313A1
(en)
|
2007-04-20 |
2008-10-30 |
Merck Frosst Canada Ltd. |
Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2008139845A1
(ja)
|
2007-04-24 |
2008-11-20 |
Daiichi Sankyo Company, Limited |
新規アミド誘導体
|
|
AU2008253512A1
(en)
|
2007-05-23 |
2008-11-27 |
Merck Frosst Canada Ltd. |
Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
|
US7842696B2
(en)
|
2007-06-21 |
2010-11-30 |
Forest Laboratories Holdings Limited |
Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
|
|
JP2009019013A
(ja)
|
2007-07-12 |
2009-01-29 |
Daiichi Sankyo Co Ltd |
新規ヘテロアリールピペリジン誘導体
|
|
GB0714129D0
(en)
|
2007-07-19 |
2007-08-29 |
Smithkline Beecham Corp |
compounds
|
|
WO2009012573A1
(en)
|
2007-07-20 |
2009-01-29 |
Merck Frosst Canada Ltd. |
Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
GB0715055D0
(en)
|
2007-08-02 |
2007-09-12 |
Smithkline Beecham Corp |
Compounds
|
|
CN101821234B
(zh)
|
2007-08-08 |
2014-06-25 |
格里斯威医药有限责任公司 |
苯氧基吡咯烷衍生物及其应用和组合物
|
|
CA2695251C
(en)
|
2007-08-14 |
2016-06-21 |
Bayer Schering Pharma Aktiengesellschaft |
Fused imidazoles for cancer treatment
|
|
WO2009037542A2
(en)
|
2007-09-20 |
2009-03-26 |
Glenmark Pharmaceuticals, S.A. |
Spirocyclic compounds as stearoyl coa desaturase inhibitors
|
|
ES2499018T3
(es)
|
2007-09-20 |
2014-09-26 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de GPR119
|
|
GB0721419D0
(en)
*
|
2007-10-31 |
2007-12-12 |
Smithkline Beecham Corp |
Compounds
|
|
GB0722075D0
(en)
|
2007-11-09 |
2007-12-19 |
Smithkline Beecham Corp |
Compounds
|
|
GB0722077D0
(en)
|
2007-11-09 |
2007-12-19 |
Smithkline Beecham Corp |
Compounds
|
|
WO2009070533A1
(en)
|
2007-11-29 |
2009-06-04 |
Complegen, Inc. |
Methods of inhibiting steroyl coa desaturase
|
|
CA2707313A1
(en)
|
2007-12-11 |
2009-06-18 |
Merck Frosst Canada Ltd. |
Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2009074487A1
(en)
|
2007-12-11 |
2009-06-18 |
F. Hoffmann-La Roche Ag |
Inhibitors of stearoyl-coa desaturase
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
ES2387714T3
(es)
|
2007-12-28 |
2012-09-28 |
Wisconsin Alumni Research Foundation |
Análogos de 2-metilen-20-metil-19,24,25,26,27-pentanor-vitamina D
|
|
CA2715947C
(en)
|
2008-02-20 |
2016-10-25 |
Novartis Ag |
Heterocyclic inhibitors of stearoyl-coa desaturase
|
|
CA2716109C
(en)
*
|
2008-02-28 |
2016-07-19 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl derivatives as cftr modulators
|
|
WO2009117676A2
(en)
|
2008-03-20 |
2009-09-24 |
Forest Laboratories Holdings Limited |
Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
|
|
AU2009225513C1
(en)
|
2008-03-20 |
2012-01-12 |
Forest Laboratories Holdings Limited |
Novel piperazine derivatives as inhibitors of stearoyl-CoA desaturase
|
|
NZ616097A
(en)
|
2008-03-31 |
2015-04-24 |
Vertex Pharma |
Pyridyl derivatives as cftr modulators
|
|
JP2011516498A
(ja)
|
2008-04-04 |
2011-05-26 |
ギリアード サイエンシーズ， インコーポレイテッド |
ステアロイル−ＣｏＡデサチュラーゼの阻害剤として使用するためのトリアゾロピリジノン誘導体
|
|
CA2719362A1
(en)
|
2008-04-04 |
2009-10-08 |
Gilead Sciences, Inc. |
Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
|
|
CA2719376A1
(en)
|
2008-04-07 |
2009-10-15 |
Gilead Sciences, Inc. |
2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
AU2009240747A1
(en)
|
2008-04-22 |
2009-10-29 |
Merck Frosst Canada Ltd |
Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
|
GB0810913D0
(en)
|
2008-06-13 |
2008-07-23 |
Smithkline Beecham Corp |
Comppounds
|
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
WO2009156484A2
(en)
|
2008-06-27 |
2009-12-30 |
Novartis Ag |
Organic compounds
|
|
TWI434842B
(zh)
|
2008-07-14 |
2014-04-21 |
Astellas Pharma Inc |
Azole compounds
|
|
FR2933979B1
(fr)
|
2008-07-15 |
2012-08-24 |
Pf Medicament |
Derives de triazines et uraciles, leur preparation et leur application en therapeutique humaine
|
|
WO2010007482A2
(en)
|
2008-07-16 |
2010-01-21 |
Glenmark Pharmaceuticals S.A. |
Thiazole derivatives as stearoyl coa desaturase inhibitors
|
|
GB0813740D0
(en)
|
2008-07-28 |
2008-09-03 |
Angeletti P Ist Richerche Biologica |
Therapeutic compounds
|
|
JP2010043052A
(ja)
|
2008-08-18 |
2010-02-25 |
Mitsubishi Chemicals Corp |
カロテノイド類の分離方法
|
|
WO2010022055A2
(en)
|
2008-08-20 |
2010-02-25 |
Amgen Inc. |
Inhibitors of voltage-gated sodium channels
|
|
EP2334666A1
(en)
|
2008-09-08 |
2011-06-22 |
Merck Canada Inc. |
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010028761A1
(de)
|
2008-09-09 |
2010-03-18 |
Sanofi-Aventis |
2-heteroaryl-pyrrolo[3, 4-c]pyrrol-derivate und ihre verwendung als scd inhibitoren
|
|
WO2010039186A2
(en)
|
2008-09-23 |
2010-04-08 |
Renovis, Inc. |
Compounds useful as faah modulators and uses thereof
|
|
US20110184027A1
(en)
|
2008-09-25 |
2011-07-28 |
Glenmark Pharmaceuticals S.A. |
Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification
|
|
JP2012504557A
(ja)
|
2008-10-02 |
2012-02-23 |
メルク カナダ インコーポレイテッド |
ステアロイルコエンザイムａデルタ−９デサチュラーゼの阻害剤としての芳香族複素環化合物
|
|
WO2010045374A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
CA2740389A1
(en)
|
2008-10-15 |
2010-05-20 |
Gilead Sciences, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
WO2010045371A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
Pyrido- and pyrimido (1, 2-a) pyrimidine compounds useful as stearoyl coa desaturase inhibitors
|
|
US20110183958A1
(en)
|
2008-10-17 |
2011-07-28 |
Merck Frosst Canada Ltd. |
Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
EP2192196A1
(en)
|
2008-11-27 |
2010-06-02 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Prediction of lipid-metabotype-related physiological susceptibilities
|
|
US20100160323A1
(en)
|
2008-12-23 |
2010-06-24 |
Alexander Bischoff |
NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
|
|
WO2010094120A1
(en)
|
2009-02-17 |
2010-08-26 |
Merck Frosst Canada Ltd. |
Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
CA2750635A1
(en)
|
2009-02-23 |
2010-08-26 |
Merck Canada Inc. |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
ES2761295T3
(es)
|
2009-03-02 |
2020-05-19 |
Stemsynergy Therapeutics Inc |
Métodos y composiciones para su uso en el tratamiento del cáncer y para reducir los efectos mediados por Wnt en una célula
|
|
US20120010186A1
(en)
|
2009-03-23 |
2012-01-12 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010112520A1
(en)
|
2009-04-01 |
2010-10-07 |
Novartis Ag |
Spiro derivatives for the modulation of stearoyl-coa desaturase
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
US8383643B2
(en)
|
2009-07-28 |
2013-02-26 |
Merck Canada Inc. |
Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
|
FR2948939B1
(fr)
|
2009-08-05 |
2013-03-22 |
Pf Medicament |
Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine
|
|
US8354403B2
(en)
|
2009-08-27 |
2013-01-15 |
Merck Sharp & Dohme Corp. |
Pyrrolidine derived beta 3 adrenergic receptor agonists
|
|
DK2473045T3
(en)
|
2009-09-01 |
2016-12-12 |
Catabasis Pharmaceuticals Inc |
Niacin-FATTY ACID CONJUGATES AND THEIR USES
|
|
EP2475367A1
(en)
|
2009-09-10 |
2012-07-18 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
|
AU2010302577A1
(en)
|
2009-10-01 |
2012-03-15 |
Novartis Ag |
Pyrazole derivatives which modulate stearoyl-CoA desaturase
|
|
WO2011047481A1
(en)
|
2009-10-23 |
2011-04-28 |
Merck Frosst Canada Ltd. |
Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2011079274A1
(en)
|
2009-12-23 |
2011-06-30 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
|
CA2791738C
(en)
|
2010-03-01 |
2020-06-09 |
Gtx, Inc. |
Aryl imidazolyl compounds for the treatment of cancer
|
|
US8796254B2
(en)
|
2010-03-31 |
2014-08-05 |
Rigel Pharmaceuticals, Inc. |
Methods for using carboxamide, sulfonamide and amine compounds
|
|
FR2958935B1
(fr)
|
2010-04-19 |
2012-06-22 |
Pf Medicament |
Derives d'heterocycles azotes, leur preparation et leur application en therapeutique humaine
|
|
JP2013532149A
(ja)
|
2010-06-17 |
2013-08-15 |
ノバルティス アーゲー |
ピペリジニル置換１，３−ジヒドロ−ベンゾイミダゾール−２−イリデンアミン誘導体
|
|
US20130259830A1
(en)
|
2010-07-12 |
2013-10-03 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
HUE052110T2
(hu)
|
2010-07-29 |
2021-04-28 |
Rigel Pharmaceuticals Inc |
AMPK-t aktiváló heterociklusos vegyületek és alkalmazásuk
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
DK2616465T3
(da)
|
2010-09-13 |
2016-02-01 |
Novartis Ag |
Triazin-oxadiazoler
|
|
JPWO2012046681A1
(ja)
|
2010-10-04 |
2014-02-24 |
興和株式会社 |
脂質代謝関連ｍＲＮＡの発現抑制剤
|
|
GB201114389D0
(en)
|
2011-08-22 |
2011-10-05 |
Prosidion Ltd |
Novel compounds
|
|
AR083904A1
(es)
|
2010-11-18 |
2013-04-10 |
Prosidion Ltd |
Derivados de 1,4-pirrolidinas disustituidos y 3-il-aminas y sus usos en el tratamiento de desordenes metabolicos
|
|
EP2455080A1
(en)
|
2010-11-23 |
2012-05-23 |
Almirall, S.A. |
S1P1 receptor agonists for use in the treatment of multiple sclerosis
|
|
EP2455081A1
(en)
|
2010-11-23 |
2012-05-23 |
Almirall, S.A. |
S1P1 receptor agonists for use in the treatment of crohn's disease
|
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
|
EP2651930B1
(en)
*
|
2010-12-16 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Biarylamide inhibitors of leukotriene production
|
|
KR20120079015A
(ko)
|
2011-01-03 |
2012-07-11 |
한미약품 주식회사 |
Ｇ 단백질-커플링된 수용체의 조절을 위한 신규한 비사이클릭 화합물
|
|
WO2012123449A1
(en)
|
2011-03-14 |
2012-09-20 |
Boehringer Ingelheim International Gmbh |
N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators
|
|
JP2014513071A
(ja)
|
2011-04-04 |
2014-05-29 |
シエナ ビオテク ソシエタ ペル アチオニ |
ウィント経路遮断薬
|
|
CA2833507A1
(en)
|
2011-06-07 |
2012-12-13 |
Dainippon Sumitomo Pharma Co., Ltd. |
Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
|
|
WO2012170931A2
(en)
*
|
2011-06-10 |
2012-12-13 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2013004642A1
(en)
|
2011-07-01 |
2013-01-10 |
Remynd Nv |
1, 2, 4 -thiadiazol- 5 -ylpiperazine derivatives useful in the treatment neurodegenerative diseases
|
|
CN103930424A
(zh)
|
2011-09-01 |
2014-07-16 |
Irm责任有限公司 |
作为c-Kit激酶抑制剂的化合物和组合物
|
|
MX342326B
(es)
|
2011-09-27 |
2016-09-26 |
Novartis Ag |
3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.
|
|
US9358250B2
(en)
|
2011-10-15 |
2016-06-07 |
Genentech, Inc. |
Methods of using SCD1 antagonists
|
|
WO2013070660A1
(en)
|
2011-11-07 |
2013-05-16 |
Emory University |
Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
|
|
WO2013085957A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
|
|
WO2013085954A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors
|
|
US8530461B2
(en)
|
2011-12-29 |
2013-09-10 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives
|
|
WO2013130625A1
(en)
|
2012-02-27 |
2013-09-06 |
Basil Rigas |
Phospho-ester derivatives and uses thereof
|
|
WO2013134546A1
(en)
|
2012-03-07 |
2013-09-12 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
IN2014MN02269A
(enExample)
|
2012-04-23 |
2015-07-24 |
Piramal Entpr Ltd |
|
|
WO2013170072A2
(en)
|
2012-05-09 |
2013-11-14 |
Neurop, Inc. |
Compounds for the treatment of neurological disorders
|
|
MX2014014174A
(es)
|
2012-05-22 |
2015-07-06 |
Hoffmann La Roche |
Inhibidores selectivos de celulas no diferenciadas.
|
|
WO2014003153A1
(ja)
|
2012-06-28 |
2014-01-03 |
協和発酵キリン株式会社 |
置換アミド化合物
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
BR112015007516A2
(pt)
|
2012-10-10 |
2017-07-04 |
Actelion Pharmaceuticals Ltd |
antagonistas do receptor de orexina que são derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)- pirrolidin-1-il]-metanona
|
|
WO2014065860A1
(en)
*
|
2012-10-24 |
2014-05-01 |
The General Hospital Corporation |
Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
|
|
MX2015006930A
(es)
|
2012-12-03 |
2015-09-08 |
Hoffmann La Roche |
Compuestos de isoxazol amina sustituidos como inhibidores de scd1.
|
|
KR20150090100A
(ko)
|
2012-12-03 |
2015-08-05 |
에프. 호프만-라 로슈 아게 |
스테아로일-CoA 불포화화효소 1(에스씨디 1)의 억제제로서의 치환된 이속사졸 아마이드 화합물
|
|
JP2016028016A
(ja)
|
2012-12-12 |
2016-02-25 |
大日本住友製薬株式会社 |
オキサジアゾール誘導体とその医薬用途
|
|
US9416102B2
(en)
|
2013-01-23 |
2016-08-16 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
|
|
TWI594975B
(zh)
*
|
2013-04-24 |
2017-08-11 |
第一三共股份有限公司 |
二羧酸化合物
|
|
KR101524650B1
(ko)
|
2013-07-30 |
2015-06-03 |
경상대학교산학협력단 |
테트라하이드로이소퀴놀린 알칼로이드계 화합물 ｙｓ－５１ｓ를 포함하는 대사성 질환의 예방 및 치료용 조성물
|
|
KR20150015305A
(ko)
|
2013-07-31 |
2015-02-10 |
안동대학교 산학협력단 |
주박 추출물을 유효성분으로 함유하는 비만의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
|
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
|
WO2015054658A1
(en)
*
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
CN104163794A
(zh)
|
2013-10-17 |
2014-11-26 |
中国药科大学 |
2-氨基芳环类血管内皮生长因子受体(vegfr)抑制剂及其制备方法和用途
|
|
RU2670762C2
(ru)
|
2013-12-31 |
2018-10-25 |
Хуаньчжу Фарма Ко., Лтд. |
Производные 6-(пиримидиноаминопиридин)бензоимидазола, полезные для лечения рака
|
|
WO2015113920A1
(en)
|
2014-01-29 |
2015-08-06 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted isothiazoles
|
|
GB201403969D0
(en)
|
2014-03-06 |
2014-04-23 |
Isis Innovation |
Compounds for use in controlling body fat
|
|
US20170015654A1
(en)
|
2014-03-12 |
2017-01-19 |
Takeda Pharmaceutical Company Limited |
Pyridazine compound
|
|
US10562869B2
(en)
|
2014-03-17 |
2020-02-18 |
Remynd Nv |
Oxadiazole compounds
|
|
WO2016022626A1
(en)
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
|
WO2016022955A1
(en)
|
2014-08-07 |
2016-02-11 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
|
KR101715449B1
(ko)
|
2014-08-13 |
2017-03-30 |
주식회사 큐리언트 |
염증성 질환 치료용 화합물
|
|
EP3191578B1
(en)
|
2014-09-12 |
2020-11-04 |
Whitehead Institute for Biomedical Research |
Cells expressing apolipoprotein e and uses thereof
|
|
WO2016049586A2
(en)
|
2014-09-25 |
2016-03-31 |
University Of Notre Dame Du Lac |
Non-beta lactam antibiotics
|
|
EP3034500A1
(en)
|
2014-12-17 |
2016-06-22 |
Genkyotex Sa |
Amido thiazole derivatives as NADPH oxidase inhibitors
|
|
CN105753814A
(zh)
|
2015-01-01 |
2016-07-13 |
成都贝斯凯瑞生物科技有限公司 |
取代氮杂环衍生物及其应用
|
|
US20160223559A1
(en)
*
|
2015-02-02 |
2016-08-04 |
The Regents Of The University Of California |
Tetrazine-containing compounds and synthetic methods thereof
|
|
CN107249583B
(zh)
|
2015-02-09 |
2021-05-07 |
国立大学法人冈山大学 |
乳酸脱氢酶抑制剂以及含有该抑制剂的抗癫痫剂
|
|
CN106146391A
(zh)
|
2015-04-15 |
2016-11-23 |
中国科学院上海药物研究所 |
5-芳香炔基取代的苯甲酰胺类化合物及其制备方法、药物组合物和用途
|
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
US20200262799A1
(en)
*
|
2015-11-30 |
2020-08-20 |
Universite De Bourgogne |
Process for preparing functionalized 1,2,4,5-tetrazine compounds
|
|
WO2017112777A1
(en)
|
2015-12-22 |
2017-06-29 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
RU2018145734A
(ru)
|
2016-06-08 |
2020-07-14 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Химические соединения в качестве ингибиторов atf4 пути
|
|
EP3490561A4
(en)
|
2016-08-01 |
2020-04-08 |
Ignyta, Inc. |
COMBINATIONS FOR TREATING CANCER
|
|
EP3529245A4
(en)
|
2016-10-24 |
2020-12-23 |
Yumanity Therapeutics, Inc. |
COMPOUNDS AND USES OF THE LATEST
|
|
WO2018112077A1
(en)
|
2016-12-13 |
2018-06-21 |
Centaurus Therapeutics |
Inhibitors of dihydroceramide desaturase for treating disease
|
|
MA47212A
(fr)
|
2017-01-06 |
2019-11-13 |
Yumanity Therapeutics Inc |
Méthodes de traitement de troubles neurologiques
|
|
WO2018160717A1
(en)
|
2017-02-28 |
2018-09-07 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
|
EP3381908A1
(en)
|
2017-03-27 |
2018-10-03 |
Leadiant Biosciences SA |
2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl)benzazole derivatives and their use as anti-heparanase
|
|
WO2018195450A1
(en)
|
2017-04-21 |
2018-10-25 |
Epizyme, Inc. |
Combination therapies with ehmt2 inhibitors
|
|
WO2019018795A1
(en)
|
2017-07-20 |
2019-01-24 |
Yumanity Therapeutics |
COMPOUNDS AND USES THEREOF
|
|
WO2019084157A1
(en)
|
2017-10-24 |
2019-05-02 |
Yumanity Therapeutics, Inc. |
COMPOUNDS AND USES THEREOF
|
|
US20200325148A1
(en)
|
2017-12-21 |
2020-10-15 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
|
|
EP3728201A1
(en)
|
2017-12-21 |
2020-10-28 |
Gliapharm SA |
Compositions and methods of treatment for neurological disorders comprising a dementia
|
|
EP3737361A4
(en)
|
2018-01-11 |
2021-08-25 |
Centaurus Therapeutics |
INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR THE TREATMENT OF DISEASES
|
|
ES3053087T3
(en)
|
2018-03-05 |
2026-01-19 |
Wylder Nation Found |
A fatty acid amide hydrolase (faahi) inhibitor for use in inhibiting the cellular accumulation of a sphingolipid in a subject that has lysosomal storage disease or disorder
|
|
ES3043183T3
(en)
|
2018-03-23 |
2025-11-25 |
Janssen Pharmaceutica Nv |
Compounds and uses thereof
|
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
|
CN112566636A
(zh)
|
2018-04-25 |
2021-03-26 |
优曼尼蒂治疗公司 |
化合物及其用途
|
|
WO2019209948A1
(en)
|
2018-04-25 |
2019-10-31 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
JP2021532181A
(ja)
|
2018-07-24 |
2021-11-25 |
エピザイム，インク． |
Ｓｍａｒｃａ２アンタゴニストとして有用なピリジン−２−オン化合物
|
|
WO2020132378A2
(en)
|
2018-12-22 |
2020-06-25 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising depression
|
|
MA54829A
(fr)
|
2019-01-24 |
2021-12-01 |
Yumanity Therapeutics Inc |
Composés et leurs utilisations
|
|
US20230078764A1
(en)
|
2019-03-22 |
2023-03-16 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
EP4054570A1
(en)
|
2019-11-05 |
2022-09-14 |
Dermira, Inc |
Mrgprx2 antagonists and uses thereof
|
|
US20230029266A1
(en)
|
2019-11-05 |
2023-01-26 |
Dermira, Inc. |
MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
|
|
EA202192047A1
(ru)
|
2019-11-13 |
2021-12-08 |
Юманити Терапьютикс, Инк. |
Соединения и их применение
|
|
TW202136238A
(zh)
|
2020-01-06 |
2021-10-01 |
大陸商廣東東陽光藥業有限公司 |
RORγt抑制劑及其製備方法和用途
|
|
EP4096562B1
(en)
|
2020-01-31 |
2025-03-05 |
American Sterilizer Company |
Surgical light head with beam spreading and adjustable power balancing
|